<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002020'>Gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) is a common <z:hpo ids='HP_0011010'>chronic</z:hpo> disorder affecting millions of people worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>This is a review of a number of published studies in the past year that increase current understanding or raise important issues about this disorder </plain></SENT>
<SENT sid="2" pm="."><plain>Among the areas covered are the epidemiology and role of genetics in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>; its pathogenesis with respect to <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e> and impaired epithelial barrier function; the effects of <z:chebi fb="28" ids="16684">atropine</z:chebi> on transient lower esophageal sphincter relaxations; the role of acid suppression, heat shock proteins, and the enzyme cyclooxygenase-2 in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>; the complication rates in laparoscopic fundoplication; and the results of ablation therapy for the treatment of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>These investigations reinforce a sense of the complexity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> and provide optimism that modern technology will continue to be used to develop more effective treatments </plain></SENT>
</text></document>